JP2017530185A5 - - Google Patents

Download PDF

Info

Publication number
JP2017530185A5
JP2017530185A5 JP2017518989A JP2017518989A JP2017530185A5 JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5 JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5
Authority
JP
Japan
Prior art keywords
methyl
dichlorophenyl
dihydroisoquinolin
ethanone
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518989A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017530185A (ja
JP6622299B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/073053 external-priority patent/WO2016055479A1/en
Publication of JP2017530185A publication Critical patent/JP2017530185A/ja
Publication of JP2017530185A5 publication Critical patent/JP2017530185A5/ja
Application granted granted Critical
Publication of JP6622299B2 publication Critical patent/JP6622299B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518989A 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体 Active JP6622299B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14188174.8 2014-10-08
EP14188174 2014-10-08
PCT/EP2015/073053 WO2016055479A1 (en) 2014-10-08 2015-10-06 Tetrahydroisoquinoline derivatives

Publications (3)

Publication Number Publication Date
JP2017530185A JP2017530185A (ja) 2017-10-12
JP2017530185A5 true JP2017530185A5 (enExample) 2019-10-03
JP6622299B2 JP6622299B2 (ja) 2019-12-18

Family

ID=51790569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518989A Active JP6622299B2 (ja) 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体

Country Status (18)

Country Link
US (1) US10105359B2 (enExample)
EP (1) EP3204359B1 (enExample)
JP (1) JP6622299B2 (enExample)
CN (1) CN107001278B (enExample)
BR (1) BR112017007123B1 (enExample)
CA (1) CA2963951C (enExample)
CY (1) CY1123417T1 (enExample)
DK (1) DK3204359T3 (enExample)
EA (1) EA035544B1 (enExample)
ES (1) ES2821821T3 (enExample)
HR (1) HRP20201469T1 (enExample)
HU (1) HUE050664T2 (enExample)
LT (1) LT3204359T (enExample)
PL (1) PL3204359T3 (enExample)
PT (1) PT3204359T (enExample)
RS (1) RS60933B1 (enExample)
SI (1) SI3204359T1 (enExample)
WO (1) WO2016055479A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017222958B2 (en) * 2016-02-25 2019-07-18 Asceneuron S. A. Glycosidase inhibitors
BR112018070363A2 (pt) * 2016-04-13 2019-01-29 Ucb Biopharma Sprl derivados de tetraidroisoquinolina
CN107698433A (zh) * 2017-09-12 2018-02-16 潍坊滨海石油化工有限公司 苯乙酸的制备方法
DK3717025T3 (da) 2017-12-01 2021-11-22 UCB Biopharma SRL Billeddannende midler
TWI725408B (zh) * 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑
AU2020299953B2 (en) * 2019-07-01 2025-06-05 UCB Biopharma SRL A substituted tetrahydroisoquinoline derivative as a D1 positive allosteric modulator
CA3139622A1 (en) * 2019-07-01 2021-01-07 UCB Biopharma SRL A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator
WO2021216973A1 (en) * 2020-04-24 2021-10-28 The Regents Of The University Of California Nurr1 receptor modulators and uses thereof
CN111943930B (zh) * 2020-08-25 2022-11-01 南京三元阳普医药科技有限公司 Lasmiditan的合成工艺
MA60976B1 (fr) * 2020-10-07 2024-05-31 Lilly Co Eli Dérivés de la phényl-3,4-dihydroisoquinoléine-2(1h)-yl-éthan-1-one comme modulateurs allostériques positifs du récepteur d1 de la dopamine
EP4267555A1 (en) * 2020-12-03 2023-11-01 UCB Biopharma SRL Octahydroisoquinolinyl derivatives
EP4263519B1 (en) * 2020-12-18 2024-10-02 UCB Biopharma SRL Prodrugs of 2-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl]ethanone
IL303693A (en) * 2020-12-18 2023-08-01 UCB Biopharma SRL Consequences of transformed tetrahydroisoquinoline as a positive D1 allosteric modulator
EP4263522B1 (en) 2020-12-18 2024-10-02 UCB Biopharma SRL Dihydroisoquinolinyl derivatives
CN116685308A (zh) * 2020-12-18 2023-09-01 Ucb生物制药有限责任公司 无定形固体分散体
AU2022234744B2 (en) 2021-03-08 2025-06-26 Eli Lilly And Company Use of mevidalen and other d1 positive allosteric modulators in the treatment of hallucinations and dementia-related psychosis
AU2022234226B2 (en) 2021-03-09 2025-08-14 Eli Lilly And Company Use of mevidalen and other d1 positive allosteric modulators for slowing of parkinson's disease progression
CN114671810B (zh) * 2022-03-21 2024-03-22 济南鸿湾生物技术有限公司 一种咪唑苯脲的制备方法
CN115611768B (zh) * 2022-11-14 2024-03-05 郑州大学 一种3,4-二氯苯腈的合成方法
CN118724764B (zh) * 2024-06-07 2025-11-18 绍兴文理学院 一种芳基伯磺酰胺类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766131A (en) * 1980-10-17 1988-08-23 Pennwalt Corporation 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics
JP2005518378A (ja) * 2001-12-19 2005-06-23 ハー・ルンドベック・アクチエゼルスカベット 3,4−ジヒドロ−ih−イソキノリン−2−イル誘導体
DK1749001T3 (da) * 2004-04-29 2010-06-28 Aventis Pharma Inc 3-piperidinylisochroman-5-ol som dopaminagonister
EP2125741A1 (en) * 2007-03-01 2009-12-02 Janssen Pharmaceutica, N.V. Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor

Similar Documents

Publication Publication Date Title
JP2017530185A5 (enExample)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2016517878A5 (enExample)
RU2606497C2 (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
ES2629414T3 (es) Derivados de tiazol
JP2021500345A5 (enExample)
RU2018140092A (ru) Новые пиразолпиримидиновые производные
RU2018123779A (ru) Новые соединения
JP2020506946A5 (enExample)
HRP20210143T1 (hr) 2-heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidi za liječenje raka
JP2014506599A5 (enExample)
JP2010510319A5 (enExample)
JP2016523911A5 (enExample)
JP2006500348A5 (enExample)
JP2017503837A5 (enExample)
JP2016513660A5 (enExample)
JP2017511794A5 (enExample)
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2019513776A5 (enExample)
JP2014526549A5 (enExample)
JP2019504009A5 (enExample)
JP2019508384A (ja) 5−置換2−(モルホリン−4−イル)−1,7−ナフチリジン
HRP20191821T1 (hr) Antiproliferativni spojevi i načini njihove uporabe
JP2018511587A5 (enExample)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors